Article
KRAS Mutations in Duodenal Lavage Fluid After Secretin Stimulation for Detection of Pancreatic Cancer.
Annals of surgery - 1 Oct 2026
Yachida Shinichi, Yoshinaga Shigetaka, Shiba Satoshi, Urabe Makiko, Tanaka Hidenori, Takeda Yohei, Shimizu Akinori, Sakamoto Yuri, Hijioka Susumu, Haba Shin, Ashida Reiko, Kushiyama Yoshinori, Asano Kento, Kobayashi Makiko, Murawaki Yoshiyuki, Onishi Kouji, Yamashita Taro, Kimura Hirokazu, Totoki Yasushi, Kamada Hideki, Isomoto Hajime, Hattori Satoshi, Morizane Chigusa, Ohkawa Kazuyoshi, Kitano Masayuki, Hara Kazuo, Ikezawa Kenji, Hanada Keiji, Matsumoto Kazuya
Abstract excerpt
OBJECTIVE: Although pancreatic ductal adenocarcinoma (PDAC) is still a devastating disease, the survival rate for surgically removed PDACs has significantly improved in recent years. Early detection is essential in managing PDAC. BACKGROUND: The presence of KRAS mutations in PDAC leads to the initial genetic abnormality and offers a significant timeframe for identifying resectable PDACs. A minimally invasive and...
Read the complete abstract on PubMedTopics
- Humans
- Secretin
- Pancreatic Neoplasms
- Proto-Oncogene Proteins p21(ras)
